SLXN
Biomotion Sciences Ordinary Shares
NASDAQ: SLXN · HEALTHCARE · BIOTECHNOLOGY
$0.61
-3.00% today
Updated 2026-04-30
Market cap
$2.60M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.96
Dividend yield
—
52W range
$0 – $22
Volume
0.1M
Biomotion Sciences Ordinary Shares (SLXN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-911000.00 | $-75000.00 | $-1.41M | $-3.33M | $-4.53M | $-8.40M | $-10.82M |
| Capital expenditures | $3000.00 | $0.00 | $4.00 | $40000.00 | $12000.00 | $22000.00 | $9000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $125000.00 | $130000.00 | $5.86M | $134000.00 |
| Free cash flow | $-914000.00 | $-75000.00 | $-1.41M | $-3.38M | $-4.54M | $-8.42M | $-10.83M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |